Christian Angermayer - 22 Jun 2021 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role: Director, 10%+ Owner
Signature: /s/ Ryan Barrett, Attorney-in-fact
Issuer symbol: ATAI
Transactions as of: 22 Jun 2021
Net transactions value: +$10,500,000
Form type: 4
Filing time: 24 Jun 2021, 16:15:40 UTC
Previous filing: 25 Aug 2021
Next filing: 13 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATAI	Common Shares	Purchase	$10,500,000	+700,000	+3.6%	$15.00^*	20,185,200	22 Jun 2021	By Apeiron Investment Group Ltd.	F1
holding	ATAI	Common Shares						1,187,104	22 Jun 2021	By Presight II, L.P.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Apeiron Investment Group Ltd. is the co-managing member of Presight Capital Management I, LLC, which is the general partner of Presight II, L.P. Therefore, Apeiron Investment Group Ltd. may be deemed to share beneficial ownership of the Common Shares held by Presight II, L.P. Apeiron Investment Group Ltd. is owned and controlled by Christian Angermayer. Mr. Angermayer may be deemed to have beneficial ownership over the shares held by Apeiron Investment Group Ltd. and Presight II, L.P.

Content

Apeiron Investment Group Ltd. is the co-managing member of Presight Capital Management I, LLC, which is the general partner of Presight II, L.P. Therefore, Apeiron Investment Group Ltd. may be deemed to share beneficial ownership of the Common Shares held by Presight II, L.P. Apeiron Investment Group Ltd. is owned and controlled by Christian Angermayer. Mr. Angermayer may be deemed to have beneficial ownership over the shares held by Apeiron Investment Group Ltd. and Presight II, L.P.